A critical review of adult health maintenance. Part 2. Prevention of infectious diseases.
Frame
P S
PS
D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use; D002170:Canada; D002648:Child; D003140:Communicable Disease Control; D004168:Diphtheria Toxoid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000517:prevention & control; D011008:Pneumococcal Infections / Q000517:prevention & control; D012306:Risk; D012411:Rubella Vaccine / Q000627:therapeutic use; D013587:Syphilis / Q000517:prevention & control; D013745:Tetanus Toxoid / Q000627:therapeutic use; D014481:United States; D014611:Vaccination
D001500:BCG Vaccine; D004168:Diphtheria Toxoid; D007252:Influenza Vaccines; D012411:Rubella Vaccine; D013745:Tetanus Toxoid